BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
United Kingdom Statutory Instruments |
||
|
You are here: BAILII >> Databases >> United Kingdom Statutory Instruments >> The Medicines and Healthcare Products Regulatory Agency Trading Fund (Revocation) Order 2022 No. 90 URL: http://www.bailii.org/uk/legis/num_reg/2022/uksi_202290_en_1.html |
||
[New search] [Help]
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Statutory Instruments
Government Trading Funds
Made
31st January 2022
Laid before the House of Commons
1st February 2022
Coming into force - -
1st April 2022
The Secretary of State, in exercise of the powers conferred by sections 1 and 6(1) of the Government Trading Funds Act 1973( 1), with concurrence of the Treasury, makes the following Order:
1. This Order may be cited as the Medicines and Healthcare Products Regulatory Agency Trading Fund (Revocation) Order 2022 and comes into force on 1st April 2022.
2. The instruments specified in the Schedule are revoked to the extent shown in that Schedule.
Signed by authority of the Secretary of State for Health and Social Care
Kamall
Parliamentary Under Secretary of State
Department of Health and Social Care
27th January 2022
Craig Whittaker
Rebecca Harris
Two of the Lord Commissioners
Her Majesty’s Treasury
31st January 2022
Article 2
| Instrument | Reference | Extent of Revocation |
|---|---|---|
|
(1)
S.I. 2003/1076, amended by S.I. 2004/994, 2005/2061, 2006/2407, 2012/1916, 2014/432, 2016/549, 2018/378and 1112. | ||
|
(2)
S.I. 2004/994, to which there are amendments not relevant to this instrument. | ||
|
(3)
S.I. 2006/2407, to which there are amendments not relevant to this instrument. | ||
|
(4)
S.I. 2012/1916, to which there are amendments not relevant to this instrument. | ||
| The Medicines Control Agency Trading Fund (Variation) Order 1997 | S.I. 1997/805 | Entire Order |
| The Medicines and Healthcare Products Regulatory Agency Trading Fund Order 2003 (1) | S.I. 2003/1076 | Entire Order |
| The Good Laboratory Practice (Codification Amendments Etc.) Regulations 2004 (2) | S.I. 2004/994 | Regulation 3 |
| The Medicines and Healthcare Products Regulatory Agency Trading Fund (Amendment) Order 2005 | S.I. 2005/2061 | Entire Order |
| The Veterinary Medicines Regulations 2006 (3) | S.I. 2006/2407 | Paragraph 12 of Part 2 of Schedule 8 |
| The Human Medicines Regulations 2012 (4) | S.I. 2012/1916 | Paragraph 78 of Part 5 of Schedule 34 |
| The Medicines and Healthcare Products Regulatory Agency Trading Fund (Appropriation of Additional Assets and Liabilities) Order 2014 | S.I. 2014/432 | Entire Order |
| The Medicines and Healthcare Products Regulatory Agency Trading Fund (Amendment) Order 2016 | S.I. 2016/549 | Entire Order |
| The Secretaries of State for Health and Social Care and for Housing, Communities and Local Government and Transfer of Functions (Commonhold Land) Order 2018 | S.I. 2018/378 | Paragraphs 20(e) and 21(h) of Part 2 of Schedule 1 |
| The Medicines and Healthcare Products Regulatory Agency Trading Fund (Amendment) (EU Exit) Order 2018 | S.I. 2018/1112 | Entire Order |
(This note is not part of the Order)
This Order revokes the Medicines and Healthcare Products Regulatory Agency Trading Fund Order 2003 (‘the 2003 Order’) and all other amending Statutory Instruments or provisions that will become spent when the 2003 Order is revoked, with effect from 1st April 2022. This Order also revokes the Medicines Control Agency Trading Fund (Variation) Order 1997, which became spent when the Medicines Control Agency Trading Order 1993 was revoked and replaced by the 2003 Order.
The trading fund established by the 2003 Order will cease to exist, the operations of MHRA as defined in Schedule 1 to the 2003 Order will cease to be funded by means of a trading fund, and MHRA’s assets and liabilities will no longer be appropriated to a trading fund. MHRA will remain an Executive Agency sponsored by the Department of Health and Social Care.
A full impact assessment has not been produced for this instrument as no, or no significant impact on the private, voluntary or public sector is foreseen.
An Explanatory Memorandum is available alongside this instrument onwww.legislation.gov.uk.
1973 c. 63; sections 1 and 6(1) were amended by the Government Trading Act 1990 (c. 30), sections 1(1) and 2(3)(a) respectively.
